Neurocognitive Disorders
115
32
39
43
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
3 terminated out of 115 trials
93.5%
+7.0% vs benchmark
5%
6 trials in Phase 3/4
16%
7 of 43 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 43 completed trials
Clinical Trials (115)
Cognitive Disorders and Brain Pulse
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Creatine and Perioperative Brain Health
Brain Stimulation and Cognitive Training for MCI
rTMS for Apathy Clinical Trial
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
Cognitive Stimulation in Older Adults With Alzheimer's Disease
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
Adapted Physical Activity Education in Patients With Neurocognitive Disorder
Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA)
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics
Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.
Nutrition-based Interventions to Prevent Cognitive Decline
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients